These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5058095)

  • 41. [Microcirculation and the nature of morphological changes in the gastric and duodenal mucosa in children with scleroderma].
    Vlasova TM; Sokolovskiĭ GA; Chumakov AM; Daurova NV; Uvarova NN
    Pediatriia; 1983 Nov; (11):48-50. PubMed ID: 6669435
    [No Abstract]   [Full Text] [Related]  

  • 42. Control trials of dimethyl sulfoxide in rheumatoid and collagen diseases.
    Alyabyeva AP; Muravyev YuV
    Ann N Y Acad Sci; 1983; 411():309-15. PubMed ID: 6576704
    [No Abstract]   [Full Text] [Related]  

  • 43. A clinical trial with dimethyl sulfoxide in scleroderma.
    Tuffanelli DL
    Arch Dermatol; 1966 Jun; 93(6):724-5. PubMed ID: 5326715
    [No Abstract]   [Full Text] [Related]  

  • 44. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 45. ALTERATION OF COLLAGEN IN GENERALIZED SCLERODERMA (PROGRESSIVE SYSTEMIC SCLEROSIS) AFTER TREATMENT WITH DIMETHYL SULFOXIDE: PRELIMINARY REPORT.
    SCHERBEL AL; MCCORMACK LJ; POPPO MJ
    Cleve Clin Q; 1965 Apr; 32():47-56. PubMed ID: 14288161
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic effectiveness of carbon dioxide-hydrosulfide baths of Piatigorsk in complex therapy for children with scleroderma].
    Braĭtsev AV; Studnitsin AA; Nikitina MN; Kessel' VP; Marzeva GI
    Pediatriia; 1971 Nov; 50(11):30-2. PubMed ID: 4259038
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnosis and treatment of scleroderma.
    Adnan ZA
    Acta Med Indones; 2008 Apr; 40(2):109-12. PubMed ID: 18560030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Electrocardiographic disorders in diverse clinical variations of scleroderma].
    Targa L; Cardin G; Cozzi F; Glorioso S; Rossi L; Todesco S
    G Clin Med; 1990 Jan; 71(1):17-24. PubMed ID: 2142111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discussion paper: methodology and techniques in the evaluation of dimethyl sulfoxide for connective tissue disorders.
    Fleischmajer R
    Ann N Y Acad Sci; 1975 Jan; 243():393-4. PubMed ID: 1055555
    [No Abstract]   [Full Text] [Related]  

  • 50. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
    Baum S; Pavlotsky F; Shpiro D; Trau H
    Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
    [No Abstract]   [Full Text] [Related]  

  • 51. Photochemotherapy for systemic and localized scleroderma.
    De Rie MA; Bos JD
    J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
    [No Abstract]   [Full Text] [Related]  

  • 52. Salazopyrin in the treatment of scleroderma.
    Stáva Z; Kobíková M
    Br J Dermatol; 1977 May; 96(5):541-4. PubMed ID: 17429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapeutic effectiveness of treatment of patients with scleroderma at the Pyatigorsk Spa].
    Braĭtsev AV; Kessel' VP; Marzeeva GI; Shliapak EA; Angelova VS
    Vestn Dermatol Venerol; 1971 Oct; 45(10):35-9. PubMed ID: 5134075
    [No Abstract]   [Full Text] [Related]  

  • 54. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
    Daróczy J; Gyöngyvér S
    Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
    [No Abstract]   [Full Text] [Related]  

  • 55. [Physical factors in the pathogenetic therapy of children with scleroderma].
    Popik GS; Riabova TV; Martynovets LV; Kolesnikova TV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (4):46-8. PubMed ID: 2275105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis.
    Scherbel AL
    Ann N Y Acad Sci; 1983; 411():120-30. PubMed ID: 6576688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vascular reactions in the fingers in scleroderma].
    Dosychev EA; Mikheev GN
    Vestn Dermatol Venerol; 1978 Sep; (9):7-11. PubMed ID: 706749
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dynamics of hydroxyproline content as the indicator of the severity of the course and the effectiveness of treatment of focal scleroderma].
    Fedorova EG; Lashmanova AP
    Vestn Dermatol Venerol; 1978 Dec; (12):18-22. PubMed ID: 570330
    [No Abstract]   [Full Text] [Related]  

  • 59. [Characteristics of the course of scleroderma in diabetes mellitus].
    Khamaganova IV
    Sov Med; 1990; (2):72-6. PubMed ID: 2356535
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclosporin in localized and systemic scleroderma--a clinical study.
    Wörle B; Hein R; Krieg T; Meurer M
    Dermatologica; 1990; 181(3):215-20. PubMed ID: 2269381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.